Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.

Rinkenbaugh AL, Cogswell PC, Calamini B, Dunn DE, Persson AI, Weiss WA, Lo DC, Baldwin AS.

Oncotarget. 2016 Oct 25;7(43):69173-69187. doi: 10.18632/oncotarget.12507.

2.

IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity.

Bassères DS, Ebbs A, Cogswell PC, Baldwin AS.

Genes Cancer. 2014 Apr;5(1-2):41-55.

3.

Essential role for epidermal growth factor receptor in glutamate receptor signaling to NF-kappaB.

Sitcheran R, Comb WC, Cogswell PC, Baldwin AS.

Mol Cell Biol. 2008 Aug;28(16):5061-70. doi: 10.1128/MCB.00578-08. Epub 2008 Jun 9.

4.

Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK.

Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS.

Genes Dev. 2008 Jun 1;22(11):1490-500. doi: 10.1101/gad.1662308.

5.

Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion.

Gilbert MR, Carnathan DG, Cogswell PC, Lin L, Baldwin AS Jr, Vilen BJ.

J Immunol. 2007 Apr 15;178(8):4803-10.

6.

Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.

Steinbrecher KA, Wilson W 3rd, Cogswell PC, Baldwin AS.

Mol Cell Biol. 2005 Oct;25(19):8444-55.

7.
8.
9.

A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression.

Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, Baldwin AS.

Nature. 2003 Jun 5;423(6940):659-63.

PMID:
12789343
10.

NF-kappa B and I kappa B alpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappa B.

Cogswell PC, Kashatus DF, Keifer JA, Guttridge DC, Reuther JY, Bristow C, Roy S, Nicholson DW, Baldwin AS Jr.

J Biol Chem. 2003 Jan 31;278(5):2963-8. Epub 2002 Nov 13.

11.

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.

Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS Jr.

Oncogene. 2000 Feb 24;19(9):1123-31.

12.

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin AS Jr.

Science. 1997 Dec 5;278(5344):1812-5.

14.

Effects of HIV-1 Tat on expression of HLA class I molecules.

Matsui M, Warburton RJ, Cogswell PC, Baldwin AS Jr, Frelinger JA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 1;11(3):233-40.

PMID:
8603259
15.

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr.

Science. 1995 Oct 13;270(5234):283-6.

PMID:
7569975
16.
17.

Mechanism of c-myc regulation by c-Myb in different cell lineages.

Cogswell JP, Cogswell PC, Kuehl WM, Cuddihy AM, Bender TM, Engelke U, Marcu KB, Ting JP.

Mol Cell Biol. 1993 May;13(5):2858-69.

18.

Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.

Cogswell PC, Scheinman RI, Baldwin AS Jr.

J Immunol. 1993 Apr 1;150(7):2794-804.

PMID:
8454856
19.

axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.

O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R 3rd, Le Beau MM, Earp HS, Liu ET.

Mol Cell Biol. 1991 Oct;11(10):5016-31.

20.

Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.

Cogswell PC, Morgan R, Dunn M, Neubauer A, Nelson P, Poland-Johnston NK, Sandberg AA, Liu E.

Blood. 1989 Dec;74(8):2629-33.

PMID:
2684296

Supplemental Content

Loading ...
Support Center